Filing Flows › PTC Therapeutics (PTCT) › Who owns the stock
Who owns PTC Therapeutics (PTCT) stock
352 funds reported PTC Therapeutics (PTCT) shares in their latest 13F filings, worth $9.2B in all. The largest holder is BlackRock ($1.1B). Last quarter 188 funds added to their stakes and 145 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| BlackRock | 13,964,554 | $1.1B | increase | 2026-06-30 |
| Vanguard Group | 8,803,203 | $669M | increase | 2025-12-31 |
| RTW Investments, LP | 7,746,415 | $632M | unchanged | 2026-06-30 |
| Jupiter Topco LLC | 7,236,402 | $590M | base | 2026-06-30 |
| Janus Henderson Group | 7,193,433 | $490M | increase | 2026-03-31 |
| Vanguard Portfolio Management LLC | 4,928,111 | $402M | increase | 2026-06-30 |
| State Street | 4,598,952 | $375M | increase | 2026-06-30 |
| Wellington Management Group LLP | 4,128,273 | $337M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 3,739,127 | $305M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 2,207,376 | $180M | decrease | 2026-06-30 |
| Toronto Dominion Bank | 2,165,846 | $177M | decrease | 2026-06-30 |
| Westfield Capital Management Co LP | 1,956,156 | $160M | new | 2026-06-30 |
| Hood River Capital Management LLC | 1,738,613 | $142M | increase | 2026-06-30 |
| William Blair Investment Management, LLC | 1,722,688 | $141M | new | 2026-06-30 |
| D. E. Shaw | 1,548,919 | $126M | decrease | 2026-06-30 |
PTC Therapeutics' latest quarter
PTC Therapeutics, Q3 2026: revenue $358M (+70% year over year), operating margin 7.0%, net loss $51.7M, operating cash flow −$25.3M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most PTCT stock?
By the latest 13F filings: BlackRock ($1.1B); Vanguard Group ($669M); RTW Investments, LP ($632M); Jupiter Topco LLC ($590M); Janus Henderson Group ($490M).
What is the short interest in PTCT?
8,303,282 shares were sold short at the 2026-10-15 settlement, -9.44% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.